These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30579414)

  • 1. Residual neuromuscular block in paediatric anaesthesia.
    Klucka J; Kosinova M; Krikava I; Stoudek R; Toukalkova M; Stourac P
    Br J Anaesth; 2019 Jan; 122(1):e1-e2. PubMed ID: 30579414
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and validation of an android-based application for anaesthesia neuromuscular monitoring.
    Carvalho H; Verdonck M; Berghmans J; Poelaert J
    J Clin Monit Comput; 2019 Oct; 33(5):863-870. PubMed ID: 30446866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block.
    Suzuki T; Fukano N; Kitajima O; Saeki S; Ogawa S
    Br J Anaesth; 2006 Jan; 96(1):44-7. PubMed ID: 16299046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-Based Management of Neuromuscular Block, Reversal, and Recovery: Ensuring Optimal Outcomes.
    AANA J; 2015 Dec; Suppl():4-15. PubMed ID: 26749974
    [No Abstract]   [Full Text] [Related]  

  • 6. Arm-to-arm variation when evaluating neuromuscular block: an analysis of the precision and the bias and agreement between arms when using mechanomyography or acceleromyography.
    Claudius C; Skovgaard LT; Viby-Mogensen J
    Br J Anaesth; 2010 Sep; 105(3):310-7. PubMed ID: 20595196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-establishment of neuromuscular block by rocuronium after sugammadex administration.
    Fabregat-López J; Veiga-Ruiz G; Dominguez-Serrano N; García-Martinez MR
    Can J Anaesth; 2011 Jul; 58(7):658. PubMed ID: 21468657
    [No Abstract]   [Full Text] [Related]  

  • 9. Hidden universality of residual neuromuscular block.
    Eikermann M
    Br J Anaesth; 2016 Mar; 116(3):435-6. PubMed ID: 26865141
    [No Abstract]   [Full Text] [Related]  

  • 10. Sugammadex and residual neuromuscular block: what is acceptable normal practice?
    Todd MM
    Br J Anaesth; 2016 Mar; 116(3):434-5. PubMed ID: 26865140
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuromuscular monitoring, reversal and postoperative residual neuromuscular block: An intradepartmental survey over the years.
    Cammu GV; Klewais LR; Vandeput DM; Foubert LA
    Anaesth Intensive Care; 2020 Jan; 48(1):73-75. PubMed ID: 31979984
    [No Abstract]   [Full Text] [Related]  

  • 12. Postoperative residual curarization and evidence-based anaesthesia.
    Viby-Mogensen J
    Br J Anaesth; 2000 Mar; 84(3):301-3. PubMed ID: 10793585
    [No Abstract]   [Full Text] [Related]  

  • 13. Reasoning of an anomaly: residual block after sugammadex.
    Naguib M; Brull SJ; Arkes HR
    Anesth Analg; 2013 Aug; 117(2):297-300. PubMed ID: 23881373
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparing for the unexpected: special considerations and complications after sugammadex administration.
    Iwasaki H; Renew JR; Kunisawa T; Brull SJ
    BMC Anesthesiol; 2017 Oct; 17(1):140. PubMed ID: 29041919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy alters cisatracurium induced neuromuscular blockade characteristics: A prospective cohort study.
    Zanjani AP; Maghsoudloo M; Makarem J; Farokhnia F; Fazli M; Khan ZH
    J Clin Anesth; 2017 Feb; 36():84-87. PubMed ID: 28183581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular blockade in the elderly.
    Stankiewicz-Rudnicki M
    Anaesthesiol Intensive Ther; 2016; 48(4):257-260. PubMed ID: 27797097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
    Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
    Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of non-depolarising neuromuscular block: current practice.
    Kopman AF; Eikermann M
    Anaesthesia; 2009 Mar; 64 Suppl 1():22-30. PubMed ID: 19222428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.